Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Frits Van Rhee

Concepts (578)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

The timeline below shows the dates (blue tick marks) of publications associated with Frits Van Rhee's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Frits Van Rhee has written about over time.
Antigens, Neoplasm, 6 publications between 2005 and 2014, average publication date May 2008. Thalidomide, 24 publications between 2003 and 2024, average publication date January 2010. Antineoplastic Combined Chemotherapy Protocols, 42 publications between 2003 and 2024, average publication date October 2011. Transplantation, Autologous, 26 publications between 2003 and 2024, average publication date February 2012. Hematopoietic Stem Cell Transplantation, 28 publications between 2002 and 2024, average publication date April 2012. Clinical Trials as Topic, 13 publications between 2006 and 2022, average publication date October 2013. Killer Cells, Natural, 8 publications between 2007 and 2024, average publication date November 2013. Antineoplastic Agents, 18 publications between 2004 and 2024, average publication date August 2014. Neoplasm Proteins, 13 publications between 2002 and 2022, average publication date August 2014. Middle Aged, 72 publications between 2002 and 2024, average publication date December 2014. Multiple Myeloma, 159 publications between 2002 and 2024, average publication date February 2015. Humans, 210 publications between 2002 and 2024, average publication date January 2016. Interleukin-6, 12 publications between 2010 and 2023, average publication date June 2016. Monoclonal Gammopathy of Undetermined Significance, 10 publications between 2006 and 2024, average publication date March 2017. Antibodies, Monoclonal, 26 publications between 2008 and 2024, average publication date July 2017. Hematologic Neoplasms, 3 publications between 2014 and 2022, average publication date August 2017. Immunotherapy, Adoptive, 9 publications between 2005 and 2024, average publication date September 2017. Neoplasm Recurrence, Local, 15 publications between 2010 and 2024, average publication date February 2018.

To see the data from this visualization as text, click here.
Van Rhee's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description